daily glp 1 injection The Latest on GLP-1s | Lexington Medical Center Blog New clinical trial data from

Certain medications also combine GLP-1 action with hormones like Tirzepatide, which work by targeting both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors

For other individuals, however, the benefits of improved glycemic control, weight loss, and cardiovascular risk reduction may outweigh theoretical concerns

Diabetes Obes Metab 2019;21:4351 [DOI] [PMC free article] [PubMed] [Google Scholar] 63.Hinnen D

A similar increased risk for heart failure was also observed for alogliptin (3.9% vs 3.3% for placebo)

This gastric slowdown is not the same as gastroparesis, which is a medical disorder where the stomach loses the ability to contract effectively at all

Side effect rates were higher in orforglipron patients, but were consistent with injectable GLP-1s